1. Home
  2. VRME vs IMNN Comparison

VRME vs IMNN Comparison

Compare VRME & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • IMNN
  • Stock Information
  • Founded
  • VRME 1999
  • IMNN 1982
  • Country
  • VRME United States
  • IMNN United States
  • Employees
  • VRME N/A
  • IMNN N/A
  • Industry
  • VRME EDP Services
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRME Technology
  • IMNN Health Care
  • Exchange
  • VRME Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • VRME 9.2M
  • IMNN 12.1M
  • IPO Year
  • VRME N/A
  • IMNN 1985
  • Fundamental
  • Price
  • VRME $0.77
  • IMNN $0.79
  • Analyst Decision
  • VRME Strong Buy
  • IMNN Buy
  • Analyst Count
  • VRME 2
  • IMNN 2
  • Target Price
  • VRME $1.38
  • IMNN $14.00
  • AVG Volume (30 Days)
  • VRME 56.5K
  • IMNN 3.9M
  • Earning Date
  • VRME 08-12-2025
  • IMNN 08-13-2025
  • Dividend Yield
  • VRME N/A
  • IMNN N/A
  • EPS Growth
  • VRME N/A
  • IMNN N/A
  • EPS
  • VRME N/A
  • IMNN N/A
  • Revenue
  • VRME $22,903,000.00
  • IMNN N/A
  • Revenue This Year
  • VRME N/A
  • IMNN N/A
  • Revenue Next Year
  • VRME $5.93
  • IMNN N/A
  • P/E Ratio
  • VRME N/A
  • IMNN N/A
  • Revenue Growth
  • VRME N/A
  • IMNN N/A
  • 52 Week Low
  • VRME $0.55
  • IMNN $0.37
  • 52 Week High
  • VRME $5.00
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • VRME 54.08
  • IMNN 40.14
  • Support Level
  • VRME $0.70
  • IMNN $0.93
  • Resistance Level
  • VRME $0.78
  • IMNN $1.03
  • Average True Range (ATR)
  • VRME 0.05
  • IMNN 0.18
  • MACD
  • VRME -0.00
  • IMNN -0.10
  • Stochastic Oscillator
  • VRME 50.35
  • IMNN 1.39

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: